Liver transplantation and autoimmune hepatitis

Tomohiro Tanaka(University of Iowa), Norihiro Kokudo(National Center for Global Health and Medicine), Yasuhiko Sugawara(Kumamoto University)

Intractable & Rare Diseases Research

January 1, 2015

10.5582/irdr.2014.01034

Cited by 29

Related Papers

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

|Journal of Hepatology|2003|1.6k

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes

|Nature Genetics|2014|780

Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma

|Gastroenterology|2008|765

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

|Gut|2019|732

Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma

|Annals of Surgery|2005|641